MediPharm Labs reports 10% drop in Q2 revenue to $4.3M

Mugglehead
By Natalia Buendia CalvilloAug 15, 2022, 11:18 pm211 pts
Toronto-based MediPharm Labs Corp. (TSX: LABS) (OTCQX: MEDIF) (FSE: MLZ) had a revenue decrease of 10 per cent during its last quarter. On Monday, cannabinoid pharmaceutical released its financial results for its second quarter ended June and reported a gross loss of $532,000 from $403,000 in the last quarter.…

Read Article Share
Share Article
- email
- twitter
- facebook
- pocket
- reddit
- tumblr
- linkedin
- pinterest

Trending Today on NewsBudz

Banking on Change: Kevin Hart’s Mission to Bring Cannabis into the Financial Mainstream 70

High Doses Of LSD Lead To ‘Greater Reductions In Depression’ Compared To Low Doses Of The Psychedelic, New Study Finds 67

Minnesota issues first adult-use marijuana license to a cultivator 47

PinkPepper Genome Mapping Transforms CBD Hemp Cultivation and Research 46

About NewsBudz

NewsBudz is your go-to app for daily cannabis news, covering everything from medical marijuana breakthroughs to recreational cannabis trends and legalization updates.

Our platform aggregates content from over 30 top-tier cannabis news outlets to deliver a curated stream of the latest headlines, insights, and developments across the marijuana and hemp industries.

Whether you're interested in policy reform, health research, cannabis business, CBD, delta 9 products or lifestyle stories, NewsBudz keeps you informed and connected. Accessible on the web and mobile, NewsBudz makes it easy to explore, read, and share cannabis news anytime, anywhere.